Literature DB >> 12086843

Senescence: a companion in chemotherapy?

Anton Berns1.   

Abstract

Mouse lymphoma model points to an unsuspected role of drug-induced "senescence."

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12086843     DOI： 10.1016/s1535-6108(02)00063-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  6 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 2.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

3.  Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells.

Authors:  James G Jackson; Olivia M Pereira-Smith
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  A new 4-(pyridinyl)-4H-benzo[g]chromene-5,10-dione ruthenium(II) complex inducing senescence in 518A2 melanoma cells.

Authors:  Madeleine Gold; Yusufi Mujahid; Khursheed Ahmed; Hana Kostrhunova; Jana Kasparkova; Viktor Brabec; Bernhard Biersack; Rainer Schobert
Journal:  J Biol Inorg Chem       Date:  2019-06-19       Impact factor: 3.358

5.  7SL RNA represses p53 translation by competing with HuR.

Authors:  Kotb Abdelmohsen; Amaresh C Panda; Min-Ju Kang; Rong Guo; Jiyoung Kim; Ioannis Grammatikakis; Je-Hyun Yoon; Dawood B Dudekula; Ji Heon Noh; Xiaoling Yang; Jennifer L Martindale; Myriam Gorospe
Journal:  Nucleic Acids Res       Date:  2014-08-14       Impact factor: 16.971

6.  p14ARF post-transcriptional regulation of nuclear cyclin D1 in MCF-7 breast cancer cells: discrimination between a good and bad prognosis?

Authors:  Eileen M McGowan; Nham Tran; Nikki Alling; Daniel Yagoub; Lisa M Sedger; Rosetta Martiniello-Wilks
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.